300313 天山生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资18,05916.22%15,53913,58611,61410,856
投资性房地产19,879-5.59%21,05625,35135,00946,419
固定资产55,886-3.97%58,19763,44170,33366,699
在建工程7,28390.46%3,824000
无形资产51,944-2.76%53,41662,47765,71569,154
商誉0--0000
其他非流动资产23,870-7.17%25,71320,80221,49821,819
176,921-0.46%177,745185,657204,169214,949

流动资产
货币资金26,175-33.55%39,39324,50016,73547,288
应收账款32,48452.95%21,23814,14011,8827,967
存货48,13443.31%33,58818,46872,46554,171
其他流动资产9,93929.63%7,6675,4319,9798,212
116,73314.57%101,88662,540111,060117,638

流动负债
短期借款0--049,59083,04294,160
应付票据0--0000
应付帐款27,01762.94%16,58115,08619,35610,898
其他流动负债88,158122.49%39,623130,333127,273120,702
115,174104.92%56,204195,008229,671225,759
流动资产净值1,558-96.59%45,683(132,468)(118,610)(108,121)
资产总额减流动负债178,479-20.12%223,42853,18985,559106,827

非流动负债
长期借款30,500-0.33%30,60030,80000
应付债券0--0000
其他非流动负债95,230-35.78%148,27616,70713,56612,751
125,730-29.71%178,87647,50713,56612,751

总权益
    实收股本239,7790.00%239,779312,977312,977312,977
    储备项目(201,509)-3.18%(208,135)(316,757)(250,809)(228,807)
股东权益38,27020.94%31,644(3,779)62,16984,170
非控股权益14,47912.17%12,9089,4629,8249,906